l carnitine depressoon mg L-Carnitine – Carnitine Synergy (D) – Mark

Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients

Helps in weight loss

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 1999

Recovery can feel cleaner tooless of the lingering drag that follows high-effort days

The amino acids methionine and lysine are used by the body to make L-carnitine, which is a quaternary ammonium molecule